Isabel Dias

Isabel Dias, M.D., currently serves as the Medical Scientific Affairs Manager at B. Braun Group since May 2019, focusing on identifying medical trends and supporting product development. Previously, Isabel Dias held roles at Pfizer from April 2010 to March 2019 as a Senior Medical Advisor/Manager for both Anti-infectives and Established Products Business Units, where responsibilities included strategic medical planning and market access. From June 2006 to February 2010, Isabel Dias worked as a Medical Director at UCB, reorganizing the Medical Department. Early career highlights include positions at Sanofi, Hoechst Marion Roussel/Aventis, Novartis, and Sandoz, encompassing various medical management roles and responsibilities in clinical trials, marketing, and pharmacovigilance. Isabel Dias earned a Doctor of Medicine degree from NOVA Medical School and completed an executive education program at INSEAD.